Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott’s Libre 3.
Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA
Where Today's News Shapes Tomorrow
February 22, 2026
Headlines
